Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Omada Health, Inc. (OMDA) Institutional Ownership & Insider Trading

153 institutions reported holding Omada Health, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 61 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

OMDAOmada Health, Inc.Follow OMDA — free
Health Information Services · Healthcare
—
Price chart with a free account
Market cap
1.2B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
5 Nov, in 12 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

153 institutions held 85.9% of the shares. Across filers that reported both quarters, shares held changed +9.0%.

Increased+63New+34Decreased-38Closed-15

Largest moves, shares (millions)

Morgan Stanley+1.3MAmerican Century Companies+1.2MOberweis Asset Management…+1.0MDivisadero Street Capital…-2.1Ma16z Capital Management-1.2MSG Americas Securities-0.7M

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters
+0.0Jun 25+5.7Sep 25+6.3Dec 25+2.1Mar 26+4.3Jun 26
QuarterHoldersShares held, MChangeIncreasedNewDecreasedClosed
Jun 2615353+9.0%63343815
Mar 2613948+4.7%41393033
Dec 2513243+20.2%35591415
Sep 258431+22.0%16381424
Jun 256826—————

Omada Health, Inc. — questions

Who owns Omada Health, Inc. stock?
153 institutions reported Omada Health, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: Revelation Capital Management, LLC (7.9%), Divisadero Street Capital Management, LP (6.2%), AMERICAN CENTURY COMPANIES INC (6.0%).
Are Omada Health, Inc. insiders buying or selling?
61 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Omada Health, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.